Can GLP-1 medications reduce acne and hirsutism in PCOS?

GLP-1 receptor agonists may offer metabolic and hormonal benefits in women with PCOS. Studies show they support weight loss and can modestly reduce total testosterone, which may help some androgen-related symptoms. Evidence for improvement in hirsutism is mixed, and evidence for acne improvement is limited because it is not routinely measured in trials.

Key points:

  • GLP-1 receptor agonists support weight loss and improve metabolic parameters in PCOS.
  • Clinical studies show modest reductions in total testosterone levels.
  • Some studies report small improvements in hirsutism scores, though findings vary.
  • Evidence for acne improvement is limited and not consistently measured.
  • Benefits are largely linked to weight loss and metabolic changes; direct hormonal effects remain under study.

This text has been fact-checked for accuracy by Sorin Romaniuc, Pharmacist at medino.